N-acetyl-β-glucosaminidase and β-galactosidase activity in children receiving antiepileptic drugs

Pediatric Neurology

Volumn 20, Issue 1, 1999, Pages 24-26

  Yüksel, Adnan ^a   Cengiz, Müjgan ^a   Seven, Mehmet ^a   Cengiz, Salih ^a   Cenani, Asim ^a  

^a Div Neurogenetics Biochem I   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BETA GALACTOSIDASE; CARBAMAZEPINE; N ACETYL BETA GLUCOSAMINIDASE; VALPROIC ACID;

ANTICONVULSANT THERAPY; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; EPILEPSY; FEMALE; HUMAN; KIDNEY TUBULE FUNCTION; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; TREATMENT OUTCOME; URINALYSIS;

EID: 0345355141     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(98)00079-4     Document Type: Article

References (15)

1. Camfield C., Camfield P., Smith E., Tibbles J.A.R. Asymptomatic children with epilepsy Little benefit from screening for anticonvulsant induced liver, blood, or renal damage . Neurology. 36:1986;838-841.
2. Lenoir G.R., Perignon J.L., Gubler M.C., Broyer M. Valproic acid A possible cause of proximal tubular renal syndrome . J Pediatr. 98:1981;503-504.
3. Novo M.L.P., Izumi T., Yokota K., Fukuyama Y. Urinary excretion of N-acetyl β-glucosaminidase and β-galactosidase by patients with epilepsy. Brain Dev. 15:1993;157-160.
4. Watanabe K., Kojima T., Fukuda J., et al. Reliability of urinary N-acetyl-β-D glucosaminidase as an indicator of renal tubular damage in neonates. Biol Neonate. 52:1987;16-21.
5. Agirbasli M., Radhakrishnamurthy B., Jiang X., Bao W., Berenson G.S. Urinary N acetyl beta D glucosaminidase changes in relation to age, sex, race, and diastolic and systolic blood pressure in a young adult biracial population. Am J Hypertens. 9:1996;157-161.
6. Hsiao P.H., Tsai W.S., Tsai W.Y., Lee J.S., Tsau Y.K., Chen C.H. Urinary N-acetyl beta-D-glucosaminidase activity in children with insulin-dependent diabetes mellitus. Am J Nephrol. 16:1996;300-303.
7. Price R.G., Dance N., Richards B., Cattell W.R. The excretion of N-acetyl-β-glucosaminidase and β-galactosidase following surgery to the kidney. Clin Chim Acta. 27:1970;65-72.
8. Korinthenberg R., Wehrle L., Zimmerhackl L.B. Renal tubular dysfunction following treatment with antiepileptic drugs. Eur J Pediatr. 153:1994;855-858.
9. Coma P., Gomez-Chacon L., Garcia-Serrano B., Fernandez E., Ortiz-Apodaca M.A. α-Glucosidase and N-acetyl-β-D-glucosaminidase isoenzymes in serum. Clin Chem. 38:1992;223-226.
10. Wellwood J.M., Ellis B.G., Price R.G., Hammond K., Thompson A.E., Jones N.F. Urinary N-acetyl-β-D glucosaminidase activities in patients with renal disease. BMJ. 3:1975;408-411.
11. Csáthy L., Pócsi I., Kiss L., Balla G., Modi N., Price R.T. The effect of polycythemia and hypoxia on urinary N-acetyl-β-D glucosaminidase activity in newborns. Clin Chim Acta. 195:1990;77-85.
12. Dance N., Price R.G., Cattell W.R., Lansdell J., Richards B. The excretion of N-acetyl-β-D glucosaminidase and β-galactosidase by patients with renal disease. Clin Chim Acta. 27:1970;87-92.
13. Paigen K., Peterson J. Coordinacy of lysosomal enzyme excretion in human urine. J Clin Invest. 61:1978;751-762.
14. Kunin C.M., Chesney R.W., Craig W.A., England A.C., De Angelis C. Enzymuria as a marker of renal injury and disease Studies of N-Acetyl-β-D glucosaminidase in the general population and in patients with renal disease . Pediatrics. 62:1978;751-760.
15. Wellwood J.M., Simpson P.M., Tighe J.R., Thompson A.E. Evidence of gentamicin nephrotoxicity in patients with renal allografts. BMJ. 3:1975;278-281.